| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| CHD4 | EP300 | ENSCAFP00000022067 | ENSCAFP00000001585 | Chromodomain helicase DNA binding protein 4. | E1A binding protein p300. | 0.755 |
| CHD4 | IRF1 | ENSCAFP00000022067 | ENSCAFP00000001223 | Chromodomain helicase DNA binding protein 4. | Interferon regulatory factor 1. | 0.885 |
| ENSCAFP00000058070 | EP300 | ENSCAFP00000058070 | ENSCAFP00000001585 | Uncharacterized protein. | E1A binding protein p300. | 0.857 |
| ENSCAFP00000058070 | IRF1 | ENSCAFP00000058070 | ENSCAFP00000001223 | Uncharacterized protein. | Interferon regulatory factor 1. | 0.941 |
| EP300 | CHD4 | ENSCAFP00000001585 | ENSCAFP00000022067 | E1A binding protein p300. | Chromodomain helicase DNA binding protein 4. | 0.755 |
| EP300 | ENSCAFP00000058070 | ENSCAFP00000001585 | ENSCAFP00000058070 | E1A binding protein p300. | Uncharacterized protein. | 0.857 |
| EP300 | IRF1 | ENSCAFP00000001585 | ENSCAFP00000001223 | E1A binding protein p300. | Interferon regulatory factor 1. | 0.886 |
| EP300 | MDM2 | ENSCAFP00000001585 | ENSCAFP00000065951 | E1A binding protein p300. | E3 ubiquitin-protein ligase Mdm2; E3 ubiquitin-protein ligase that mediates ubiquitination of p53/TP53, leading to its degradation by the proteasome. Inhibits p53/TP53- and p73/TP73-mediated cell cycle arrest and apoptosis by binding its transcriptional activation domain. Also acts as a ubiquitin ligase E3 toward itself and ARRB1. Permits the nuclear export of p53/TP53. Promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma RB1 protein. Inhibits DAXX-mediated apoptosis by inducing its ubiquitination and degradation. Component of the TRIM28/KAP1-MDM2-p53/TP53 [...] | 0.880 |
| EP300 | STAT1 | ENSCAFP00000001585 | ENSCAFP00000048445 | E1A binding protein p300. | Signal transducer and activator of transcription. | 0.993 |
| EP300 | STAT2 | ENSCAFP00000001585 | ENSCAFP00000000180 | E1A binding protein p300. | Signal transducer and activator of transcription. | 0.963 |
| EP300 | STAT4 | ENSCAFP00000001585 | ENSCAFP00000051049 | E1A binding protein p300. | Signal transducer and activator of transcription. | 0.951 |
| IFNG | IRF1 | ENSCAFP00000000588 | ENSCAFP00000001223 | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons; Belongs to the type II (or gamma) interferon family. | Interferon regulatory factor 1. | 0.845 |
| IFNG | IRF8 | ENSCAFP00000000588 | ENSCAFP00000052304 | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons; Belongs to the type II (or gamma) interferon family. | Interferon regulatory factor 8. | 0.576 |
| IFNG | STAT1 | ENSCAFP00000000588 | ENSCAFP00000048445 | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons; Belongs to the type II (or gamma) interferon family. | Signal transducer and activator of transcription. | 0.961 |
| IFNG | STAT2 | ENSCAFP00000000588 | ENSCAFP00000000180 | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons; Belongs to the type II (or gamma) interferon family. | Signal transducer and activator of transcription. | 0.766 |
| IFNG | STAT4 | ENSCAFP00000000588 | ENSCAFP00000051049 | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons; Belongs to the type II (or gamma) interferon family. | Signal transducer and activator of transcription. | 0.797 |
| IRF1 | CHD4 | ENSCAFP00000001223 | ENSCAFP00000022067 | Interferon regulatory factor 1. | Chromodomain helicase DNA binding protein 4. | 0.885 |
| IRF1 | ENSCAFP00000058070 | ENSCAFP00000001223 | ENSCAFP00000058070 | Interferon regulatory factor 1. | Uncharacterized protein. | 0.941 |
| IRF1 | EP300 | ENSCAFP00000001223 | ENSCAFP00000001585 | Interferon regulatory factor 1. | E1A binding protein p300. | 0.886 |
| IRF1 | IFNG | ENSCAFP00000001223 | ENSCAFP00000000588 | Interferon regulatory factor 1. | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons; Belongs to the type II (or gamma) interferon family. | 0.845 |